Literature DB >> 25828685

REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders.

L Ferini-Strambi1, S Marelli1, A Galbiati1, F Rinaldi1, E Giora1.   

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) can occur in the absence of any other obvious associated neurologic disorder or in association with a neurodegenerative disease, in which case it is considered as symptomatic RBD. RBD is frequently associated with Parkinson's disease (PD), Lewy body dementia or multiple system atrophy (MSA), and in several cases may even antedate the occurrence of motor symptoms by decades. When no neurologic disorder is obvious, RBD can be considered as idiopathic (iRBD). Several studies have looked at neurophysiologic and neuropsychological functions in iRBD and have found evidence of CNS dysfunction during both wakefulness and sleep in a variable proportion of these patients, challenging the concept of iRBD. Identifying subjects with a high risk of developing a neurodegenerative process may be crucial in order to develop early intervention strategies. Some prospective results in iRBD showed that potential markers of neurodegeneration are the following: 1) marked EEG slowing on spectral analysis; 2) decreased striatal 123I-FPCIT; 3) impaired color vision.

Entities:  

Mesh:

Year:  2014        PMID: 25828685     DOI: 10.12871/000298292014238

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  8 in total

1.  The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.

Authors:  A Seifan; R Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2015-10-01

Review 2.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 3.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

4.  Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson's Disease.

Authors:  Jiangnan Ma; Kaixin Dou; Ruize Liu; Yajin Liao; Zengqiang Yuan; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 5.  Behavioural and Cognitive-Behavioural Treatments of Parasomnias.

Authors:  Andrea Galbiati; Fabrizio Rinaldi; Enrico Giora; Luigi Ferini-Strambi; Sara Marelli
Journal:  Behav Neurol       Date:  2015-05-25       Impact factor: 3.342

6.  Sleep Related Problems as a Nonmotor Symptom of Dentatorubropallidoluysian Atrophy.

Authors:  Hyeyun Kim; Ji Young Yun; Kyoung-Gyu Choi; Heasoo Koo; Hyun Jeong Han
Journal:  J Korean Med Sci       Date:  2018-04-11       Impact factor: 2.153

7.  Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease.

Authors:  Mahsa Dolatshahi; Shayan Pourmirbabaei; Aida Kamalian; Amir Ashraf-Ganjouei; Mehdi Yaseri; Mohammad H Aarabi
Journal:  Front Neurol       Date:  2018-07-11       Impact factor: 4.003

Review 8.  GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches.

Authors:  Giulietta M Riboldi; Alessio B Di Fonzo
Journal:  Cells       Date:  2019-04-19       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.